| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.097 | 0.09 |